329 related articles for article (PubMed ID: 26588183)
1. Safety profile of etifoxine: A French pharmacovigilance survey.
Cottin J; Gouraud A; Jean-Pastor MJ; Dautriche AD; Boulay C; Geniaux H; Auffret M; Bernard N; Descotes J; Vial T
Fundam Clin Pharmacol; 2016 Apr; 30(2):147-52. PubMed ID: 26588183
[TBL] [Abstract][Full Text] [Related]
2. Etifoxine-induced acute hepatitis: a case series.
Moch C; Rocher F; Lainé P; Lacotte J; Biour M; Gouraud A; Bernard N; Descotes J; Vial T
Clin Res Hepatol Gastroenterol; 2012 Oct; 36(5):e85-8. PubMed ID: 22633197
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
[TBL] [Abstract][Full Text] [Related]
4. Overview of adverse reactions to nefopam: an analysis of the French Pharmacovigilance database.
Durrieu G; Olivier P; Bagheri H; Montastruc JL;
Fundam Clin Pharmacol; 2007 Oct; 21(5):555-8. PubMed ID: 17868209
[TBL] [Abstract][Full Text] [Related]
5. Proactive Regional Pharmacovigilance System Versus National Spontaneous Reporting for Collecting Safety Data on Concerning Off-Label Prescribing Practices: An Example with Baclofen and Alcohol Dependence in France.
Auffret M; Labreuche J; Duhamel A; Deheul S; Cottencin O; Bordet R; Gautier S; Rolland B
Drug Saf; 2017 Mar; 40(3):257-262. PubMed ID: 27988884
[TBL] [Abstract][Full Text] [Related]
6. A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal.
Marques J; Ribeiro-Vaz I; Pereira AC; Polónia J
Int J Pharm Pract; 2014 Aug; 22(4):275-82. PubMed ID: 24188533
[TBL] [Abstract][Full Text] [Related]
7. Adverse drug reactions to self-medication: a study in a pharmacovigilance database.
Berreni A; Montastruc F; Bondon-Guitton E; Rousseau V; Abadie D; Durrieu G; Chebane L; Giroud JP; Bagheri H; Montastruc JL
Fundam Clin Pharmacol; 2015 Oct; 29(5):517-20. PubMed ID: 26215671
[TBL] [Abstract][Full Text] [Related]
8. [Adverse drug reactions in pediatrics: Experience of a regional pharmacovigilance center].
Saint-Martin C; Kanagaratnam L; de Boissieu P; Azzouz B; Abou Taam M; Trenque T
Therapie; 2016 Oct; 71(5):467-473. PubMed ID: 27203165
[TBL] [Abstract][Full Text] [Related]
9. Bevacizumab-induced serious side-effects: a review of the French pharmacovigilance database.
Taugourdeau-Raymond S; Rouby F; Default A; Jean-Pastor MJ;
Eur J Clin Pharmacol; 2012 Jul; 68(7):1103-7. PubMed ID: 22349162
[TBL] [Abstract][Full Text] [Related]
10. Frequency and Nature of Adverse Drug Reactions Due to Non-Prescription Drugs in Children: A Retrospective Analysis from the French Pharmacovigilance Database.
Durrieu G; Maupiler M; Rousseau V; Chebane L; Montastruc F; Bondon-Guitton E; Montastruc JL
Paediatr Drugs; 2018 Feb; 20(1):81-87. PubMed ID: 28766184
[TBL] [Abstract][Full Text] [Related]
11. Pharmacovigilance in ophthalmology in Switzerland: an analysis of the most frequently reported ocular adverse drug reactions within the last 25 years.
Karrer JE; Giovannoni L; Kullak-Ublick GA; Weiler S
Swiss Med Wkly; 2019 Jun; 149():w20085. PubMed ID: 31256417
[TBL] [Abstract][Full Text] [Related]
12. Paradoxical adverse drug reactions: descriptive analysis of French reports.
Hakimi Y; Petitpain N; Pinzani V; Montastruc JL; Bagheri H
Eur J Clin Pharmacol; 2020 Aug; 76(8):1169-1174. PubMed ID: 32418024
[TBL] [Abstract][Full Text] [Related]
13. Adverse drug reactions in Nigerian children: a retrospective review of reports submitted to the Nigerian Pharmacovigilance Centre from 2005 to 2012.
Obebi Cliff-Eribo K; Sammons H; Star K; Ralph Edwards I; Osakwe A; Choonara I
Paediatr Int Child Health; 2016 Nov; 36(4):300-304. PubMed ID: 26384567
[TBL] [Abstract][Full Text] [Related]
14. Adverse drug reactions associated with the use of NSAIDs: a case/noncase analysis of spontaneous reports from the French pharmacovigilance database 2002-2006.
Lapeyre-Mestre M; Grolleau S; Montastruc JL;
Fundam Clin Pharmacol; 2013 Apr; 27(2):223-30. PubMed ID: 21929527
[TBL] [Abstract][Full Text] [Related]
15. Adverse drug reactions in patients older than 70 years during the heat wave occurred in France in summer 2003: A study from the French PharmacoVigilance Database.
Michenot F; Sommet A; Bagheri H; Lapeyre-Mestre M; Montastruc JL;
Pharmacoepidemiol Drug Saf; 2006 Oct; 15(10):735-40. PubMed ID: 16924603
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of adverse reactions and pharmacovigilance research to parenterally administered shuxuening].
Yang W; Xiang YY; Xie YM; Shen H
Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):3013-8. PubMed ID: 24471322
[TBL] [Abstract][Full Text] [Related]
17. Safety of fibrinogen concentrate: analysis of more than 27 years of pharmacovigilance data.
Solomon C; Gröner A; Ye J; Pendrak I
Thromb Haemost; 2015 Apr; 113(4):759-71. PubMed ID: 25502954
[TBL] [Abstract][Full Text] [Related]
18. Adverse drug reactions of analgesic medicines: analysis of the Romanian pharmacovigilance database.
Cazacu I; Stroe R; Dondera R; Mogosan C; Haramburu F; Fourrier-Réglat A; Loghin F
Fundam Clin Pharmacol; 2018 Jun; 32(3):330-336. PubMed ID: 29314262
[TBL] [Abstract][Full Text] [Related]
19. The Social Impact of Suspected Adverse Drug Reactions: An analysis of the Canada Vigilance Spontaneous Reporting Database.
Castillon G; Salvo F; Moride Y
Drug Saf; 2019 Jan; 42(1):27-34. PubMed ID: 30121742
[TBL] [Abstract][Full Text] [Related]
20. [Adverse drug reactions (ADRs) to antimalarial drugs. Analysis of spontaneous report from the French pharmacovigilance database (1996-2000)].
Angles A; Bagheri H; Montastruc JL; Magnaval JF;
Presse Med; 2003 Jan; 32(3):106-13. PubMed ID: 12610379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
